# US 2024/0257668 A1 · 3d artificial skin model and method for producing the same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0257668 A1
- Document ID: US20240257668A1
- Status: Published application
- Kind: A1
- Application number: 18/423,327
- Filed: 2024-01-26
- Published: 2024-08-01
- Earliest claimed: 2023-01-27
- Assignees: Korea Advanced Institute of Science and Technology
- Applicants: Korea Advanced Institute of Science and Technology
- Inventors: Pilnam Kim; Youngmin Jo
- Web page: https://patentgrep.com/patent/US20240257668A1

## CPC

- G09B 23/306: {comprising real biological tissue}
- C12N 5/0602: {Vertebrate cells}
- C12N 5/0625: {Epidermal cells, skin cells; Cells of the oral mucosa}
- C12N 5/0698: {Skin equivalents}
- G01N 33/5082: {Supracellular entities, e.g. tissue, organisms}
- C12N 2501/15: Transforming growth factor beta (TGF-β)
- C12N 2501/72: Transferases [EC 2.]
- C12N 2501/90: Polysaccharides
- C12N 2501/998: Proteins not provided for elsewhere
- G09B: EDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS (devices for psychotechnics or for testing reaction times A61B5/16; games, sports, amusements A63; projectors, projector screens G03B)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present disclosure relates to a three-dimensional (3D) artificial skin model, and specifically, to a 3D artificial skin model that perfectly mimics the ridge shape of the dermal-epidermal junction, and a method for producing the same. Normal skin tissue has wavy ridges formed at the dermal-epidermal junction (DEJ), but the wavy ridges are known to flatten with aging. The artificial skin model of the present disclosure is a 3D artificial skin model that perfectly mimics the shape of the ridges at the dermal-epidermal junction. Since the artificial skin model mimics the structure and function of normal skin, it is expected to be widely used in the pharmaceutical and cosmetic fields.

## Claims

### Claim 1

A method for producing a multilayer-structured artificial skin, the method comprising steps of:
(a) preparing a first layer including collagen and stromal cells; and
(b) preparing a second layer comprising cellulose acetate and collagen,
wherein the second layer is located on the first layer.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the first layer and the second layer are attached to each other by a bioadhesive.

### Claim 3 (depends on 2)

The method according to claim 2, wherein the bioadhesive is transglutaminase 2 (TR2).

### Claim 4 (depends on 1)

The method according to claim 1, wherein the artificial skin has ridges formed at a junction between the first layer and the second layer.

### Claim 5 (depends on 1)

The method according to claim 1, wherein the stromal cells in step (a) are any one or more types of cells selected from the group consisting of fibroblasts, chondroblasts, osteoblasts, neuroglial cells, adipocytes, macrophages, and plasma cells.

### Claim 6 (depends on 1)

The method according to claim 1, further comprising step (c) of preparing a third layer comprising epithelial cells.

### Claim 7 (depends on 6)

The method according to claim 6, wherein the third layer is located on the second layer.

### Claim 8 (depends on 6)

The method according to claim 6, wherein the epithelial cells in step (c) are any one or more types of cells selected from the group consisting of simple squamous epithelium, simple cuboidal epithelium, simple columnar epithelium, stratified squamous epithelium, stratified cuboidal epithelium, stratified columnar epithelium, pseudostratified epithelium, transitional epithelium, and glandular epithelium cells.

### Claim 9 (depends on 1)

The method according to claim 1, further comprising step (d) of incubating the first layer and the second layer in a medium containing transforming growth factor-beta 2 (TGF-β2).

### Claim 10

A multilayer-structured artificial skin comprising:
a first layer comprising collagen and stromal cells; and
a second layer comprising cellulose acetate and collagen,
wherein the second layer is located on the first layer.

### Claim 11 (depends on 10)

The artificial skin according to claim 10, wherein the first layer and the second layer are attached to each other by a bioadhesive.

### Claim 12 (depends on 10)

The artificial skin according to claim 10, wherein the artificial skin has ridges formed at a junction between the first layer and the second layer.

### Claim 13 (depends on 10)

The artificial skin according to claim 10, wherein the stromal cells are any one or more types of cells selected from the group consisting of fibroblasts, chondroblasts, osteoblasts, neuroglial cells, adipocytes, macrophages, and plasma cells.

### Claim 14 (depends on 10)

The artificial skin according to claim 10, further comprising a third layer comprising epithelial cells.

### Claim 15 (depends on 14)

The artificial skin according to claim 14, wherein the epithelial cells are any one or more types of cells selected from the group consisting of simple squamous epithelium, simple cuboidal epithelium, simple columnar epithelium, stratified squamous epithelium, stratified cuboidal epithelium, stratified columnar epithelium, pseudostratified epithelium, transitional epithelium, and glandular epithelium cells.

### Claim 16 (depends on 10)

The artificial skin according to claim 10, which is for use in skin aging research.

### Claim 17 (depends on 10)

A method for screening a candidate substance for inhibiting skin aging, the method comprising steps of:
(a) preparing the artificial skin of claim 10;
(b) treating the artificial skin with a candidate substance for inhibiting skin aging; and
(c) checking changes in ridges at a junction between the first and second layers in the artificial skin.

### Claim 18 (depends on 17)

The method according to claim 17, wherein, if a density of the ridges in step (c) increased, the candidate substance is determined to be effective in inhibiting skin aging.
